Cargando…
Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa
BACKGROUND: Although significant progress has been made in clinical trials of women-controlled methods of HIV prevention such as microbicides and Pre-exposure Prophylaxis (PrEP), low adherence to experimental study products remains a major obstacle to being able to establish their efficacy in preven...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115485/ https://www.ncbi.nlm.nih.gov/pubmed/25065834 http://dx.doi.org/10.1186/1472-6874-14-88 |
_version_ | 1782328552000061440 |
---|---|
author | Magazi, Busisiwe Stadler, Jonathan Delany-Moretlwe, Sinead Montgomery, Elizabeth Mathebula, Florence Hartmann, Miriam van der Straten, Ariane |
author_facet | Magazi, Busisiwe Stadler, Jonathan Delany-Moretlwe, Sinead Montgomery, Elizabeth Mathebula, Florence Hartmann, Miriam van der Straten, Ariane |
author_sort | Magazi, Busisiwe |
collection | PubMed |
description | BACKGROUND: Although significant progress has been made in clinical trials of women-controlled methods of HIV prevention such as microbicides and Pre-exposure Prophylaxis (PrEP), low adherence to experimental study products remains a major obstacle to being able to establish their efficacy in preventing HIV infection. One factor that influences adherence is the ability of trial participants to attend regular clinic visits at which trial products are dispensed, adherence counseling is administered, and participant safety is monitored. We conducted a qualitative study of the social contextual factors that influenced adherence in the VOICE (MTN-003) trial in Johannesburg, South Africa, focusing on study participation in general, and study visits in particular. METHODS: The research used qualitative methodologies, including in-depth interviews (IDI), serial ethnographic interviews (EI), and focus group discussions (FGD) among a random sub-sample of 102 female trial participants, 18 to 40 years of age. A socio-ecological framework that explored those factors that shaped trial participation and adherence to study products, guided the analysis. Key codes were developed to standardize subsequent coding and a node search was used to identify texts relating to obstacles to visit adherence. Our analysis includes coded transcripts from seven FGD (N = 40), 41 IDI, and 64 serial EI (N = 21 women). RESULTS: Women’s kinship, social, and economic roles shaped their ability to participate in the clinical trial. Although participants expressed strong commitments to attend study visits, clinic visit schedules and lengthy waiting times interfered with their multiple obligations as care givers, wage earners, housekeepers, and students. CONCLUSIONS: The research findings highlight the importance of the social context in shaping participation in HIV prevention trials, beyond focusing solely on individual characteristics. This points to the need to focus interventions to improve visit attendance by promoting a culture of active and engaged participation. |
format | Online Article Text |
id | pubmed-4115485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41154852014-07-31 Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa Magazi, Busisiwe Stadler, Jonathan Delany-Moretlwe, Sinead Montgomery, Elizabeth Mathebula, Florence Hartmann, Miriam van der Straten, Ariane BMC Womens Health Research Article BACKGROUND: Although significant progress has been made in clinical trials of women-controlled methods of HIV prevention such as microbicides and Pre-exposure Prophylaxis (PrEP), low adherence to experimental study products remains a major obstacle to being able to establish their efficacy in preventing HIV infection. One factor that influences adherence is the ability of trial participants to attend regular clinic visits at which trial products are dispensed, adherence counseling is administered, and participant safety is monitored. We conducted a qualitative study of the social contextual factors that influenced adherence in the VOICE (MTN-003) trial in Johannesburg, South Africa, focusing on study participation in general, and study visits in particular. METHODS: The research used qualitative methodologies, including in-depth interviews (IDI), serial ethnographic interviews (EI), and focus group discussions (FGD) among a random sub-sample of 102 female trial participants, 18 to 40 years of age. A socio-ecological framework that explored those factors that shaped trial participation and adherence to study products, guided the analysis. Key codes were developed to standardize subsequent coding and a node search was used to identify texts relating to obstacles to visit adherence. Our analysis includes coded transcripts from seven FGD (N = 40), 41 IDI, and 64 serial EI (N = 21 women). RESULTS: Women’s kinship, social, and economic roles shaped their ability to participate in the clinical trial. Although participants expressed strong commitments to attend study visits, clinic visit schedules and lengthy waiting times interfered with their multiple obligations as care givers, wage earners, housekeepers, and students. CONCLUSIONS: The research findings highlight the importance of the social context in shaping participation in HIV prevention trials, beyond focusing solely on individual characteristics. This points to the need to focus interventions to improve visit attendance by promoting a culture of active and engaged participation. BioMed Central 2014-07-28 /pmc/articles/PMC4115485/ /pubmed/25065834 http://dx.doi.org/10.1186/1472-6874-14-88 Text en Copyright © 2014 Magazi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Magazi, Busisiwe Stadler, Jonathan Delany-Moretlwe, Sinead Montgomery, Elizabeth Mathebula, Florence Hartmann, Miriam van der Straten, Ariane Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa |
title | Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa |
title_full | Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa |
title_fullStr | Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa |
title_full_unstemmed | Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa |
title_short | Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa |
title_sort | influences on visit retention in clinical trials: insights from qualitative research during the voice trial in johannesburg, south africa |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115485/ https://www.ncbi.nlm.nih.gov/pubmed/25065834 http://dx.doi.org/10.1186/1472-6874-14-88 |
work_keys_str_mv | AT magazibusisiwe influencesonvisitretentioninclinicaltrialsinsightsfromqualitativeresearchduringthevoicetrialinjohannesburgsouthafrica AT stadlerjonathan influencesonvisitretentioninclinicaltrialsinsightsfromqualitativeresearchduringthevoicetrialinjohannesburgsouthafrica AT delanymoretlwesinead influencesonvisitretentioninclinicaltrialsinsightsfromqualitativeresearchduringthevoicetrialinjohannesburgsouthafrica AT montgomeryelizabeth influencesonvisitretentioninclinicaltrialsinsightsfromqualitativeresearchduringthevoicetrialinjohannesburgsouthafrica AT mathebulaflorence influencesonvisitretentioninclinicaltrialsinsightsfromqualitativeresearchduringthevoicetrialinjohannesburgsouthafrica AT hartmannmiriam influencesonvisitretentioninclinicaltrialsinsightsfromqualitativeresearchduringthevoicetrialinjohannesburgsouthafrica AT vanderstratenariane influencesonvisitretentioninclinicaltrialsinsightsfromqualitativeresearchduringthevoicetrialinjohannesburgsouthafrica |